These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33506732)

  • 1. Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cystic fibrosis patients receiving high-dose IV aminoglycosides.
    Huang SP; McKinzie CJ; Tak CR
    J Manag Care Spec Pharm; 2021 Feb; 27(2):157-165. PubMed ID: 33506732
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation.
    Colquitt JL; Jones J; Harris P; Loveman E; Bird A; Clegg AJ; Baguley DM; Proops DW; Mitchell TE; Sheehan PZ; Welch K
    Health Technol Assess; 2011 Jul; 15(26):1-200, iii-iv. PubMed ID: 21729632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes.
    Veenstra DL; Harris J; Gibson RL; Rosenfeld M; Burke W; Watts C
    Genet Med; 2007 Oct; 9(10):695-704. PubMed ID: 18073583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States.
    Sharma D; Xing S; Hung YT; Caskey RN; Dowell ML; Touchette DR
    Orphanet J Rare Dis; 2018 Sep; 13(1):172. PubMed ID: 30268148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis.
    Vijayasingam A; Frost E; Wilkins J; Gillen L; Premachandra P; Mclaren K; Gilmartin D; Picinali L; Vidal-Diez A; Borsci S; Ni MZ; Tang WY; Morris-Rosendahl D; Harcourt J; Elston C; Simmonds NJ; Shah A
    Thorax; 2020 Aug; 75(8):632-639. PubMed ID: 32409613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Screening Preschool Children for Hearing Loss in Australia.
    Gumbie M; Parkinson B; Dillon H; Bowman R; Song R; Cutler H
    Ear Hear; 2022; 43(3):1067-1078. PubMed ID: 34753856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Economic Evaluation of Australia's Newborn Hearing Screening Program: A Within-Study Cost-Effectiveness Analysis.
    Sharma R; Gu Y; Sinha K; Ching TYC; Marnane V; Gold L; Wake M; Wang J; Parkinson B
    Ear Hear; 2022; 43(3):972-983. PubMed ID: 34772837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis.
    Bloudek LM; Pandey R; Fazioli K; Ollendorf DA; Carlson JJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1046-1055. PubMed ID: 34337994
    [No Abstract]   [Full Text] [Related]  

  • 11. High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis.
    Al-Malky G; Dawson SJ; Sirimanna T; Bagkeris E; Suri R
    J Cyst Fibros; 2015 Mar; 14(2):248-54. PubMed ID: 25127922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tablet Audiometry in Canada's North: A Portable and Efficient Method for Hearing Screening.
    Rourke R; Kong DC; Bromwich M
    Otolaryngol Head Neck Surg; 2016 Sep; 155(3):473-8. PubMed ID: 27118819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review.
    Caumo DTM; Geyer LB; Teixeira AR; Barreto SSM
    Braz J Otorhinolaryngol; 2017; 83(4):464-474. PubMed ID: 27894912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes.
    Guzauskas GF; Rind DM; Fazioli K; Chapman RH; Pearson SD; Hansen RN
    J Manag Care Spec Pharm; 2021 Apr; 27(4):455-468. PubMed ID: 33769850
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminoglycoside induced ototoxicity risk in the cystic fibrosis population: The utility of large-scale screening.
    Lopes J; Vidal-Folch N; Lundquist P; Schimmenti LA; Demirel N; Dean V; Olson J; Auth T; Butz M; Reed K; Wylam M; Balcom J; Boczek NJ; Hasadsri L
    Pediatr Pulmonol; 2023 Mar; 58(3):819-824. PubMed ID: 36437230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-administered hearing loss screening using an interactive, tablet play audiometer with ear bud headphones.
    Yeung JC; Heley S; Beauregard Y; Champagne S; Bromwich MA
    Int J Pediatr Otorhinolaryngol; 2015 Aug; 79(8):1248-52. PubMed ID: 26055197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of routine hearing screening in children with cystic fibrosis on aminoglycosides: A systematic review.
    Farzal Z; Kou YF; St John R; Shah GB; Mitchell RB
    Laryngoscope; 2016 Jan; 126(1):228-35. PubMed ID: 26152803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
    Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
    Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
    Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
    JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.